Director, Corporate Partnerships And Philanthropy
Washington, Dc, Us
I created shared value between the private sector and the public sector to achieve health impact for PSI's beneficiaries and financial impact for corporate partners so that sustainable investment could be achieved.- Developed PSI’s Global Corporate Partnerships and Philanthropy strategy leading to a 600% increase ($2 million to $12 million per year) in corporate partnership support. - Prospected, fostered and stewarded partnerships with more than 10 new corporations across financial investment, pro-bono engagement and marketing and influence support. Partners included: Accenture, Astra Zeneca, Alere, Exxon Mobil, Novo Nordisk, Merck, Pfizer, Procter & Gamble, SC Johnson, Unilever and Vodafone. - Devised the ‘Zika Corporate Response’ fund in early 2016, leading to $750,000 of monetary and commodity support within the first 48 hours. Leveraging of this fund gained support from traditional government donors resulting in a total fund of more than $4 million.- Created PSI’s ‘Partnership in Practice’ curriculum for the development of stronger partnership practices within the 9,000 strong global PSI workforce to develop and sustain partnerships across offices in more than 50 countries.